Recurrent in-frame insertion in C/EBPα TAD2 region is a polymorphism without prognostic value in AML
- 13 September 2007
- journal article
- Published by Springer Nature in Leukemia
- Vol. 22 (3), 655-657
- https://doi.org/10.1038/sj.leu.2404926
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) GroupLeukemia, 2007
- A recurrent in-frame insertion in a CEBPA transactivation domain is a polymorphism rather than a mutation that does not affect gene expression profiling–based clustering of AMLBlood, 2007
- The Proline-Histidine-Rich CDK2/CDK4 Interaction Region of C/EBPα Is Dispensable for C/EBPα-Mediated Growth Regulation In VivoMolecular and Cellular Biology, 2006
- C/EBPα and the pathophysiology of acute myeloid leukemiaCurrent Opinion in Hematology, 2006
- CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)Blood, 2005
- CEBPA point mutations in hematological malignanciesLeukemia, 2005
- CEBPA Mutations in Younger Adults With Acute Myeloid Leukemia and Normal Cytogenetics: Prognostic Relevance and Analysis of Cooperating MutationsJournal of Clinical Oncology, 2004
- C/EBPα Arrests Cell Proliferation through Direct Inhibition of Cdk2 and Cdk4Molecular Cell, 2001